Dr. Melissa Carpenter is an inventor on a growing number of U.S. issued patents related to stem cell research, therapies and technologies. For details on a particular patent, contact us.

Melissa Carpenter Patents
2015 - Mandalam, R, Xu, C, Gold, JD, Carpenter, MK. Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation. WO8951800

2014 - Kelly O, Baetge EE, Carpenter M. Expansion of definitive endoderm cells. WO 8658151

2014 - Mandalam, R, Xu, C, Gold, JD, Carpenter, MK. Human embryonic stem cells genetically modified to contain a nucleic acid and cultures with fibroblast growth factor. WO 8637311

2013 - Mandalam, R, Faouzi, S, Nadeau, I, Pfendler-Bonham, K., Rao, N, Carpenter, MK, Rambhatla, L, Chiu, CP. Protocols for making hepatocytes from embryonic stem cells. WO8546139

2012 - Carpenter, MK, Thies, RS Neural cell populations from primate pluripotent stem cells. WO8252586

2012 - Carpenter, MK Neural progenitor cell populations. WO8252585

2012 - Carpenter, MK, Thies, RS. Use of TGF beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells. WO 8153428

2012 - Carpenter, MK Neural progenitor cell populations. WO8148148

2012 - Mandalam, R, Xu, C, Gold, JD, Carpenter, MK. Micro-carrier culture system for rapid expansion of human embryonic stem cells. WO8097458

2010 - Carpenter, MK, Thies, RS. Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells. WO7763463

2009 - Kelly, O, Baetge, EE, Carpenter, MK. Expansion of definitive endoderm cells. WO 7625753

2009 - Carpenter, MK, Thies, RS. Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells. WO7560281

2009 - Mandalam, R, Faouzi, S, Nadeau, I, Pfendler-Bonham, K., Rao, N, Carpenter, MK, Rambhatla, L, Chiu, CP. Protocols for making hepatocytes from embryonic stem cells. WO7473555

2008 - Gold, JD, Carpenter, MK, Inokuma, MS, Xu, C. Human embryonic stem cells having genetic modifications. WO7413904

2008 - Mandalam, R, Xu, C, Gold, JD, Carpenter, MK. Culture system for rapid expansion of humane embryonic stem cells. WO7410798

2007 - Rambhatla L, Carpenter MK. Hepatocytes for therapy and drug screening made from embryonic stem cells. WO7282366

2007 - Rambhatla L, Carpenter MK. Process for making hepatocytes from pluripotent stem cells. WO7250294

2007 - Carpenter MK, Denham JJ, Inokuma MS, Thies RS. Screening small molecule drugs using neural cells differentiated from human embryonic stem cells. WO7250294

2006 - Carpenter MK, Inokuma MS, Xu C. Use of human embryonic stem cells for drug screening and toxicity testing. WO7041438

2004 - Carpenter MK. Making neural cells for human therapy or drug screening from human embryonic stem cells. WO6833269

2004 - Carpenter M. Cultures of human CNS Neural stem cells. WO6777233

2003 - Funk WD, Carpenter MK, Gold JD, Inokuma MS, Xu C. cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells. WO6667176

2003 - Lyman SD, Beckmann MP, Baum PR, Carpenter MK. Methods for using elk-L to enhance neuronal survival. WO6540992

2003 - Rambhatla L, Carpenter MK. Hepatocyte lineage cells derived from pluripotent stem cells. WO6506574

2002 - Carpenter M. Cultures of human CNS neural stem cells. WO6498018

2002 - Rambhatla L, Carpenter MK. Hepatocyte lineage cells derived from pluripotent stem cells. WO6458589

2000 - Carpenter M. Cultures of human CNS neural stem cells. WO6103530

1999 - Carpenter M. Human CNS neural stem cells. WO5968829

1996 - Lyman SD, Beckmann MP, Baum PR, Carpenter MK. Cytokine designated elk ligand. WO5512457